Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
This report contains market size and forecasts of Endometriosis Drugs in Global, including the following market information:
- Global Endometriosis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Endometriosis Drugs market was valued at 1909.9 million in 2021 and is projected to reach US$ 2246.3 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormonal Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endometriosis Drugs include AbbVie, Astellas Pharma, AstraZeneca, Debiopharm Group, Evotec, Kissei Pharmaceutical, Neurocrine Biosciences, ObsEva and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Endometriosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endometriosis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Endometriosis Drugs Market Segment Percentages, by Type, 2021 (%)
- Hormonal Therapy
- Add-back Medication
- Progestogens
- Chinese Herbs
Global Endometriosis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Endometriosis Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Research Institutes
Global Endometriosis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Endometriosis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Endometriosis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Endometriosis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- Astellas Pharma
- AstraZeneca
- Debiopharm Group
- Evotec
- Kissei Pharmaceutical
- Neurocrine Biosciences
- ObsEva
- Pfizer
- Repros Therapeutics
- Roivant Sciences
- Takeda Pharmaceutical Company
- ValiRx
